|
[1]
|
Chamot AM, Benhamou CL, Kahm MF, et al. Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases[J]. Rev Rheum, 1987, 54:187-196. http://europepmc.org/abstract/MED/2954204 |
|
[2]
|
Huber CE, Judex AG, Freyschmidt J, et al. Sequential combination therapy leading to sustained remission in a patient with SAPHO syndrome[J]. Open Rheumatol J, 2009, 3:18-21. doi: 10.2174/1874312900903010018 |
|
[3]
|
Kahn MF, Khan MA. The SAPHO syndrome[J]. Baillieres Clin Rheumatol, 1994, 8:333-362. doi: 10.1016/S0950-3579(94)80022-7 |
|
[4]
|
Hukuda S, Minami M, Saito T, et al. Spondyloarthropathies in Japan:nationwide questionnaire survey performed by the Japan Ankylosing Spondylitis Society[J]. J Rheumatol, 2001, 28:549-554. http://www.ncbi.nlm.nih.gov/pubmed/11296958 |
|
[5]
|
Govoni M, Colina M, Massara A, et al."SAPHO syndrome and infections"[J].Autoimmu Rev, 2009, 8:256-259. doi: 10.1016/j.autrev.2008.07.030 |
|
[6]
|
Magrey M, Khan MA. New insights into synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome[J]. Curr Rheumatol Rep, 2009, 11:329-333. doi: 10.1007/s11926-009-0047-8 |
|
[7]
|
Rohekar G, Inman RD. Conundrums in nosology:synovitis, acne, pustulosis, hyperostosis and osteitis syndrome and spondylarthritis[J]. Arthritis Rheum, 2006, 55:665-669. doi: 10.1002/art.22087 |
|
[8]
|
Queiro R, Moreno P, Sarasqueta C, et al. Synovitis-acne-pustulosis-hyperostosis-osteitis syndrome and psoriatic arthritis exhibit adifferent immunogenetic profile[J]. Clin Exp Rheumatol, 2008, 26:125-128. http://rheumatology.oxfordjournals.org/external-ref?access_num=18328159&link_type=MED |
|
[9]
|
Utumi ER, Oliveira Sales MA, Shinohara EH, et al. SAPHO syndrome with temporomandibular joint ankylosis:clinical, radiological, histopathological, and therapeutical correlations[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2008, 105:67-72. doi: 10.1016/j.tripleo.2007.09.010 |
|
[10]
|
Hayem G, Bouchaud-Chabot A, Benali K, et al. SAPHO syndrome:a long-term follow-up study of 120 cases[J]. Semin Arthritis Rheum, 1999, 29:159-171. doi: 10.1016/S0049-0172(99)80027-4 |
|
[11]
|
Colina M, Govoni M, Orzincolo C, et al. Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome:a single center study of a cohort of 71 subjects[J]. Arthritis Care Res, 2009, 61:813-821. doi: 10.1002/art.24540 |
|
[12]
|
Assmann G, Kueck O, Kirchhoff T, et al. Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation:an interventional study[J]. Arthritis Res Ther, 2009, 11:R140. doi: 10.1186/ar2812 |
|
[13]
|
Zhao Z, Li Y, Li Y, et al. Synovitis, acne, pustulosis, hyperostosis and osteitis(SAPHO) syndrome with review of the relevant published work[J]. J Dermatol, 2011, 38:155-159. doi: 10.1111/j.1346-8138.2010.00931.x |
|
[14]
|
Garcovich S, Amelia R, Magarelli N, et al. Long-term of severe SAPHO syndrome with adalimumab:case report and a review of the literature[J]. Am J Clin Dermatol, 2012, 13:55-59. doi: 10.2165/11593250-000000000-00000 |
|
[15]
|
Ben Abdelghani K, Dran DG, Gottenberg JE, et al. Tumor necrosis factor-alpha blockers in SAPHO syndrome[J]. J Rheumatol, 2010, 37:1699-1704. doi: 10.3899/jrheum.091086 |
|
[16]
|
Amital H, Applbaum YH, Aamar S, et al. SAPHO syndrome treated with pamidronate:An open-label study of 10 patients[J]. Rheumatology (Oxford), 2004, 43:658-661. doi: 10.1093/rheumatology/keh149 |
|
[17]
|
Fruehauf J, Cierny-Modre B, Caelen Lel-S, et al. Response to infliximab in SAPHO syndrome[J]. BMJ Case Rep, 2009:2009. http://www.ncbi.nlm.nih.gov/pubmed/21686446 |
|
[18]
|
Massara A, Cavazzini PL, Trotta F. In SAPHO syndrome anti-TNF-α therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations[J]. Rheumatology (Oxford), 2006, 45:730-733. doi: 10.1093/rheumatology/kei221 |
|
[19]
|
Rozin AP. SAPHO syndrome:is a range of pathogen-associated rheumatic diseases extended?[J].Arthritis Res Ther, 2009, 11:131. doi: 10.1186/ar2837 |
|
[20]
|
Colina M, La Corte R, Trotta F. Sustained remission of SAPHO syndrome with pamidronate:a follow-up of fourteen cases and a review of the literature[J]. Clin Exp Rheumatol, 2009, 27:112-115. http://new.med.wanfangdata.com.cn/Paper/Detail?id=PeriodicalPaper_JJ026522212 |
|
[21]
|
Solau-Gervais E, Soubrier M, Gerot I, et al. The usefulness of bone remodelling markers in predicting the efficacy of pamidronate treatment in SAPHO syndrome[J]. Rheumatology (Oxford), 2006;45:339-342. doi: 10.1093/rheumatology/kei160 |
|
[22]
|
Ichikawa J, Sato E, Haro H, et al. Successful treatment of SAPHO syndrome with an oral bisphosphonate[J]. Rheumatol Int, 2009, 29:713-715. doi: 10.1007/s00296-008-0760-z |
|
[23]
|
周彩云, 马芳, 唐今扬.中西医结合治疗SAPHO综合征1例[J].中国中西医结合杂志, 2010, 30:1219-1220. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zxyjh201808027 |
|
[24]
|
汪元, 刘健, 黄传兵, 等.中西医结合治疗SAPHO综合征2例[J].罕少见病杂志, 2009, 16:39-40. http://d.wanfangdata.com.cn/Periodical/hsjbzz200906014 |
|
[25]
|
刘颖, 董振华.柴胡桂枝汤加减治疗SAPHO综合征2例[J].环球中医药, 2012, 5:60-62. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=hqzyy201201021 |
|
[26]
|
李忱, 李菁, 刘晋河, 等. SAPHO综合征12例临床分析[J].医学研究杂志, 2012, 41:117-122. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=yxyjtx201212036 |
|
[27]
|
Yanamoto S, Kawasaki G, Yoshitomi I, et al. Diffuse chronic sclerosing osteomyelitis of the mandible with synovitis, acne, pustulosis, hyperostosis, and osteitis:report of a long-term follow-up case[J]. J Oral Maxillofac Surg, 2010, 68:212-217. doi: 10.1016/j.joms.2009.04.121 |
|
[28]
|
Zemann W, Pau M, Feichtinger M, et al. SAPHO syndrome with affection of the mandible:diagnosis, treatment, and review of literature[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2011, 111:190-195. doi: 10.1016/j.tripleo.2010.04.037 |
作者投稿
专家审稿
编辑办公
邮件订阅
RSS
点击查看大图
下载:
